MY193688A - Anti-transthyretin antibodies - Google Patents

Anti-transthyretin antibodies

Info

Publication number
MY193688A
MY193688A MYPI2017702751A MYPI2017702751A MY193688A MY 193688 A MY193688 A MY 193688A MY PI2017702751 A MYPI2017702751 A MY PI2017702751A MY PI2017702751 A MYPI2017702751 A MY PI2017702751A MY 193688 A MY193688 A MY 193688A
Authority
MY
Malaysia
Prior art keywords
ttr
antibodies
accumulation
transthyretin
amyloidosis
Prior art date
Application number
MYPI2017702751A
Inventor
Yue Liu
Tarlochan S Nijjar
Avijit Chakrabartty
Jeffrey N Higaki
Original Assignee
Univ Health Network
Prothena Biosciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Health Network, Prothena Biosciences Ltd filed Critical Univ Health Network
Priority claimed from PCT/IB2016/050415 external-priority patent/WO2016120810A1/en
Publication of MY193688A publication Critical patent/MY193688A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides antibodies that specifically bind transthyretin (TTR). The antibodies can be used for treating or effecting prophylaxis of diseases or disorders associated with TTR accumulation or accumulation of TTR deposits (e.g., TTR amyloidosis). The antibodies can also be used for diagnosing TTR amyloidosis and inhibiting or reducing aggregation of TTR, among other applications. (Figure 1A.1, Figure 1A.2 and Figure 1B)
MYPI2017702751A 2015-01-28 2016-01-28 Anti-transthyretin antibodies MY193688A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562109002P 2015-01-28 2015-01-28
PCT/IB2016/050415 WO2016120810A1 (en) 2015-01-28 2016-01-28 Anti-transthyretin antibodies

Publications (1)

Publication Number Publication Date
MY193688A true MY193688A (en) 2022-10-25

Family

ID=58951280

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017702751A MY193688A (en) 2015-01-28 2016-01-28 Anti-transthyretin antibodies

Country Status (2)

Country Link
AR (1) AR103549A1 (en)
MY (1) MY193688A (en)

Also Published As

Publication number Publication date
AR103549A1 (en) 2017-05-17

Similar Documents

Publication Publication Date Title
PH12017501318A1 (en) Anti-transthyretin antibodies
SA517381991B1 (en) Anti-Transthyretin Antibodies
SA517381981B1 (en) Anti-transthyretin antibodies
WO2018007924A3 (en) Anti-transthyretin antibodies
MX2020003041A (en) Anti-transthyretin antibodies.
WO2018007923A3 (en) Anti-transthyretin antibodies
WO2018007922A3 (en) Anti-transthyretin antibodies
MX2018008369A (en) Anti-pro/latent myostatin antibodies and methods of use thereof.
PH12020550141A1 (en) Antibody molecules to cd138 and uses thereof
SG10201808940WA (en) Nox inhibitor and nfкb inhibitor containing methoxyflavone
PH12018500887A1 (en) Anti-htra1 antibodies and methods of use thereof
CL2020002468A1 (en) Antibodies that bind to sortilin and inhibit the binding of progranulin (divisional application 92-2018)
MX2021016098A (en) Humanized antibody molecules to cd138 and uses thereof.
EP4218817A3 (en) Methods for treating metabolic diseases by inhibiting myostatin activation
MY193688A (en) Anti-transthyretin antibodies
EA202090891A1 (en) ANTIBODY MOLECULES AGAINST CD138 AND THEIR APPLICATION
PH12020552202A1 (en) Antibody molecules to complement component 5 and uses thereof
EA202090898A1 (en) ANTITRANSTYRETIN ANTIBODIES
BR112017007112A2 (en) 1,2-benzothiazole compounds for the treatment of kidney disorders